Recent Finacing
Recent Raise
Epirium is a clinical-stage biopharmaceutical developing IP-protected small molecules that stimulate mitochondrial biogenesis via a previously undescribed hormonal pathway to promote tissue regeneration, advancing candidates in neuromuscular disorders.
